NRG en nucleair in het nieuws	Krantenartikelen

Zoeken in NRG krantenartikelen Push to replace Petten reactor (English) Nuclear Engineering International 15 april 2003   The Netherlands is to push for political and industrial support throughout the EU, to ensure the continued production of medical isotopes in Europe after the country’s Petten research reactor reaches the end of its operational lifetime in 2015. An independent study by a Dutch government committee has shown that a halt in operation of the European Commission-owned high flux reactor of more than a month would lead to shortages of at least two medical isotopes, molybdenum-99 and iridium-92. The Dutch state secretary for the environment, Pieter van Geel, has told parliament that he will support the committee’s recommendation for a replacement reactor to be sited within Europe – “preferably at a location where the necessary production facilities for medical radio isotopes are already available”. Van Geel said that he would put the issue on the agenda with politicians and industry at a European level with the objective of ensuring a continuation of medical isotope production in Europe. Construction of the high-flux reactor at Petten started in 1957 and the reactor celebrated 40 years of operation in November 2001

NRG, PO Box 25, NL-1755 ZG Petten, Netherlands, Tel +31-224564080, Fax +31-224563912 Informatie: info@nrg-nl.com Update 15 april 2003